Table 3.
Antibiotic 1 | HsrA Inhibitor | FICantibiotic | FICinhibitor | FICI 2 | Interaction 3 |
---|---|---|---|---|---|
CLR | I | 1 | 1 | 2 | Neutral |
IV | 1 | 1 | 2 | Neutral | |
V | 0.5 | 0.06 | 0.56 | Additive | |
VIII | 0.5 | 0.03 | 0.53 | Additive | |
XI | 0.25 | 0.5 | 0.75 | Additive | |
XII | 0.25 | 0.5 | 0.75 | Additive | |
MTZ | I | 0.125 | 0.5 | 0.625 | Additive |
IV | 1 | 1 | 2 | Neutral | |
V | 0.125 | 0.5 | 0.625 | Additive | |
VIII | 0.5 | 0.125 | 0.625 | Additive | |
XI | 0.5 | 0.063 | 0.563 | Additive | |
XII | 0.25 | 0.25 | 0.5 | Synergism | |
LVX | I | 1 | 1 | 2 | Neutral |
IV | 1 | 1 | 2 | Neutral | |
V | 1 | 1 | 2 | Neutral | |
VIII | 1 | 1 | 2 | Neutral | |
XI | 1 | 1 | 2 | Neutral | |
XII | 0.5 | 0.5 | 1 | Neutral |
1 CLR, clarithromycin. MTZ, metronidazole. LVX, levofloxacin. 2 The fractional inhibitory concentration index (FICI) is calculated as: FICA (MICA in the presence of B/MICA alone) + FICB (MICB in the presence of A/MICB alone). 3 According to the FICI value, the interaction between two compounds against a particular bacterial strain can be classified as synergism (FICI ≤ 0.5), additive (FICI > 0.5 to ≤1), no interaction or neutral (FICI > 1 to ≤4), and antagonism (FICI > 4). FIC, fractional inhibitory concentration. MIC, minimal inhibitory concentration. A and B refer to antimicrobial A and antimicrobial B.